Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

  • Luis A. Pérez de Llano, Borja G. Cosío, Christian Domingo, Isabel Urrutia, Irina Bobolea, Antonio Valero, Luis M. Entrenas Costa, Santiago Quirce, Pilar Barranco, Nuria Marina Malanda, Luis Prieto Andrés, Francisco J. Alvarez-Gutiérrez
  • The Journal of Allergy and Clinical Immunology In Practice, September 2019, Elsevier
  • DOI: 10.1016/j.jaip.2019.01.017

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.jaip.2019.01.017

The following have contributed to this page: Dr francisco javier fj alvarez gutiérrez and Dr Luis M Entrenas Costa